Literature DB >> 19751868

Radiation effects on the auditory and vestibular systems.

Niranjan Bhandare1, William M Mendenhall, Patrick J Antonelli.   

Abstract

Definitive or postoperative radiation therapy (RT) is commonly used for the management of intracranial and extracranial head and neck tumors. Because of the variability of tumor location and dimensions, sparing of nontarget normal tissue and organs may not be possible. Treatment modalities that deliver the highest doses of radiation to the auditory system include stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) for the treatment of vestibular schwannomas (VS), and fractionated radiotherapy (FRT) or intensity-modulated radiation therapy (IMRT) for the treatment of head and neck malignancies. Radiation therapy for VS is unique because of its involvement of the inner ear and preexisting auditory and vestibular dysfunction. Auditory and vestibular dysfunction following RT for VS may be limited by limiting the total dose of cranial nerve VIII irradiation and by fractionation.

Entities:  

Mesh:

Year:  2009        PMID: 19751868     DOI: 10.1016/j.otc.2009.04.002

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

1.  Unilateral cochlea sparing in locoregionally advanced head and neck cancer: a planning study.

Authors:  L H Braun; K Braun; B Frey; S M Wolpert; H Löwenheim; D Zips; S Welz
Journal:  Strahlenther Onkol       Date:  2018-08-14       Impact factor: 3.621

2.  Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion.

Authors:  Curtis M Bryant; Roi Dagan; Adam L Holtzman; Rui Fernandes; Anthony Bunnell; William M Mendenhall
Journal:  Int J Part Ther       Date:  2021-06-25

Review 3.  A systematic review on the effect of low-dose radiation on hearing.

Authors:  Srikanth Nayak; Arivudai Nambi; Sathish Kumar; P Hariprakash; Pradeep Yuvaraj; Basavaraj Poojar
Journal:  Radiat Environ Biophys       Date:  2021-07-24       Impact factor: 1.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.